These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

987 related items for PubMed ID: 31412919

  • 1. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice.
    Yang Z, Du X, Wang C, Zhang J, Liu C, Li Y, Jiang H.
    Stem Cell Res Ther; 2019 Aug 14; 10(1):250. PubMed ID: 31412919
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. HGF-modified human umbilical cord mesenchymal stem cells rescue impaired ovarian reserve function in chemotherapy-induced POI rats by improving angiogenesis while decreasing apoptosis and fibrosis in the ovary.
    Chen J, Jia Z, Zhang F, Han C, Zhao L, Jia Y, Cui M.
    Tissue Cell; 2023 Jun 14; 82():102121. PubMed ID: 37285749
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beneficial effects of human umbilical cord mesenchymal stem cell (HUCMSC) transplantation on cyclophosphamide (CTX)-induced premature ovarian failure (POF) in Tibetan miniature pigs.
    Cai J, Liang X, Sun Y, Bao S.
    Transpl Immunol; 2024 Jun 14; 84():102051. PubMed ID: 38744348
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of human umbilical cord mesenchymal stem cell-derived conditioned medium on ovarian damage.
    Hong L, Yan L, Xin Z, Hao J, Liu W, Wang S, Liao S, Wang H, Yang X.
    J Mol Cell Biol; 2020 Jun 11; 12(5):372-385. PubMed ID: 31742349
    [Abstract] [Full Text] [Related]

  • 8. Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Improve Ovarian Function and Proliferation of Premature Ovarian Insufficiency by Regulating the Hippo Signaling Pathway.
    Li Z, Zhang M, Zheng J, Tian Y, Zhang H, Tan Y, Li Q, Zhang J, Huang X.
    Front Endocrinol (Lausanne); 2021 Jun 11; 12():711902. PubMed ID: 34456868
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human umbilical cord mesenchymal stem cells alleviate chemotherapy-induced premature ovarian insufficiency mouse model by suppressing ferritinophagy-mediated ferroptosis in granulosa cells.
    Dai W, Xu B, Ding L, Zhang Z, Yang H, He T, Liu L, Pei X, Fu X.
    Free Radic Biol Med; 2024 Aug 01; 220():1-14. PubMed ID: 38677487
    [Abstract] [Full Text] [Related]

  • 11. Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure.
    Shen J, Cao D, Sun JL.
    World J Stem Cells; 2020 Apr 26; 12(4):277-287. PubMed ID: 32399136
    [Abstract] [Full Text] [Related]

  • 12. Clusterin-carrying extracellular vesicles derived from human umbilical cord mesenchymal stem cells restore the ovarian function of premature ovarian failure mice through activating the PI3K/AKT pathway.
    He J, Ao C, Li M, Deng T, Zheng S, Zhang K, Tu C, Ouyang Y, Lang R, Jiang Y, Yang Y, Li C, Wu D.
    Stem Cell Res Ther; 2024 Sep 13; 15(1):300. PubMed ID: 39272156
    [Abstract] [Full Text] [Related]

  • 13. Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice.
    Lv X, Guan C, Li Y, Su X, Zhang L, Wang X, Xia HF, Ma X.
    J Ovarian Res; 2021 Sep 15; 14(1):119. PubMed ID: 34526090
    [Abstract] [Full Text] [Related]

  • 14. Clinical analysis of human umbilical cord mesenchymal stem cell allotransplantation in patients with premature ovarian insufficiency.
    Yan L, Wu Y, Li L, Wu J, Zhao F, Gao Z, Liu W, Li T, Fan Y, Hao J, Liu J, Wang H.
    Cell Prolif; 2020 Dec 15; 53(12):e12938. PubMed ID: 33124125
    [Abstract] [Full Text] [Related]

  • 15. Human UC-MSC-derived exosomes facilitate ovarian renovation in rats with chemotherapy-induced premature ovarian insufficiency.
    Pu X, Zhang L, Zhang P, Xu Y, Wang J, Zhao X, Dai Z, Zhou H, Zhao S, Fan A.
    Front Endocrinol (Lausanne); 2023 Dec 15; 14():1205901. PubMed ID: 37564988
    [Abstract] [Full Text] [Related]

  • 16. Effects of VEGF + Mesenchymal Stem Cells and Platelet-Rich Plasma on Inbred Rat Ovarian Functions in Cyclophosphamide-Induced Premature Ovarian Insufficiency Model.
    Vural B, Duruksu G, Vural F, Gorguc M, Karaoz E.
    Stem Cell Rev Rep; 2019 Aug 15; 15(4):558-573. PubMed ID: 31037585
    [Abstract] [Full Text] [Related]

  • 17. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) alleviate excessive autophagy of ovarian granular cells through VEGFA/PI3K/AKT/mTOR pathway in premature ovarian failure rat model.
    Dai W, Yang H, Xu B, He T, Liu L, Ma X, Ma J, Yang G, Si R, Pei X, Du X, Fu X.
    J Ovarian Res; 2023 Sep 30; 16(1):198. PubMed ID: 37777781
    [Abstract] [Full Text] [Related]

  • 18. Effects of Human Amnion-Derived Mesenchymal Stem Cell (hAD-MSC) Transplantation In Situ on Primary Ovarian Insufficiency in SD Rats.
    Feng X, Ling L, Zhang W, Liu X, Wang Y, Luo Y, Xiong Z.
    Reprod Sci; 2020 Jul 30; 27(7):1502-1512. PubMed ID: 31953773
    [Abstract] [Full Text] [Related]

  • 19. Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI).
    Ling L, Hou J, Liu D, Tang D, Zhang Y, Zeng Q, Pan H, Fan L.
    Stem Cell Res Ther; 2022 Feb 23; 13(1):79. PubMed ID: 35197118
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.